| Year |
Citation |
Score |
| 2019 |
Clark RD, Daga PR. Building a Quantitative Structure-Property Relationship (QSPR) Model. Methods in Molecular Biology (Clifton, N.J.). 1939: 139-159. PMID 30848460 DOI: 10.1007/978-1-4939-9089-4_8 |
0.318 |
|
| 2018 |
Honma M, Kitazawa A, Cayley A, Williams RV, Barber C, Hanser T, Saiakhov R, Chakravarti S, Myatt GJ, Cross KP, Benfenati E, Raitano G, Mekenyan O, Petkov P, Bossa C, ... ... Daga PR, et al. Improvement of quantitative structure-activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge Project. Mutagenesis. PMID 30357358 DOI: 10.1093/Mutage/Gey031 |
0.316 |
|
| 2018 |
Daga PR, Bolger MB, Haworth IS, Clark RD, Martin EJ. Physiologically-Based Pharmacokinetic Modeling in Lead Optimization I: Evaluation and Adaptation of GastroPlus to Predict Bioavailability of Medchem Series. Molecular Pharmaceutics. PMID 29337578 DOI: 10.1021/Acs.Molpharmaceut.7B00972 |
0.316 |
|
| 2014 |
Daga PR, Polgar WE, Zaveri NT. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification. Journal of Chemical Information and Modeling. 54: 2732-43. PMID 25148595 DOI: 10.1021/Ci500291A |
0.325 |
|
| 2012 |
Fu G, Nan X, Liu H, Patel RY, Daga PR, Chen Y, Wilkins DE, Doerksen RJ. Implementation of multiple-instance learning in drug activity prediction. Bmc Bioinformatics. 13: S3. PMID 23046442 DOI: 10.1186/1471-2105-13-S15-S3 |
0.566 |
|
| 2012 |
Liu S, Patel RY, Daga PR, Liu H, Fu G, Doerksen RJ, Chen Y, Wilkins DE. Combined rule extraction and feature elimination in supervised classification. Ieee Transactions On Nanobioscience. 11: 228-36. PMID 22987128 DOI: 10.1109/Tnb.2012.2213264 |
0.557 |
|
| 2012 |
Daga PR, Zaveri NT. Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation. Proteins. 80: 1948-61. PMID 22489047 DOI: 10.1002/Prot.24077 |
0.306 |
|
| 2011 |
Nan X, Fu G, Zhao Z, Liu S, Patel RY, Liu H, Daga PR, Doerksen RJ, Dang X, Chen Y, Wilkins D. Leveraging domain information to restructure biological prediction. Bmc Bioinformatics. 12: S22. PMID 22166097 DOI: 10.1186/1471-2105-12-S10-S22 |
0.531 |
|
| 2011 |
Liu S, Patel RY, Daga PR, Liu H, Fu G, Doerksen R, Chen Y, Wilkins D. Multi-class joint rule extraction and feature selection for biological data Proceedings - 2011 Ieee International Conference On Bioinformatics and Biomedicine, Bibm 2011. 476-481. DOI: 10.1109/BIBM.2011.82 |
0.532 |
|
| 2010 |
Dayan FE, Daga PR, Duke SO, Lee RM, Tranel PJ, Doerksen RJ. Biochemical and structural consequences of a glycine deletion in the alpha-8 helix of protoporphyrinogen oxidase. Biochimica Et Biophysica Acta. 1804: 1548-56. PMID 20399914 DOI: 10.1016/J.Bbapap.2010.04.004 |
0.566 |
|
| 2010 |
Daga PR, Duan J, Doerksen RJ. Computational model of hepatitis B virus DNA polymerase: molecular dynamics and docking to understand resistant mutations. Protein Science : a Publication of the Protein Society. 19: 796-807. PMID 20162615 DOI: 10.1002/Pro.359 |
0.58 |
|
| 2010 |
Daga PR, Patel RY, Doerksen RJ. Template-based protein modeling: recent methodological advances. Current Topics in Medicinal Chemistry. 10: 84-94. PMID 19929829 DOI: 10.2174/156802610790232314 |
0.562 |
|
| 2009 |
Kudrimoti S, Ahmed SA, Daga PR, Wahba AE, Khalifa SI, Doerksen RJ, Hamann MT. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity. Bioorganic & Medicinal Chemistry. 17: 7517-22. PMID 19800245 DOI: 10.1016/J.Bmc.2009.09.012 |
0.577 |
|
| 2009 |
Prasanna S, Daga PR, Xie A, Doerksen RJ. Glycogen synthase kinase-3 inhibition by 3-anilino-4-phenylmaleimides: insights from 3D-QSAR and docking. Journal of Computer-Aided Molecular Design. 23: 113-27. PMID 18839067 DOI: 10.1007/S10822-008-9244-1 |
0.562 |
|
| 2009 |
Daga P, Odde S, Hamann M, Doerksen R. Free Energy Calculations on the Binding of Natural Latrunculins and Semi-synthetic Derivatives to G-Actin Planta Medica. 75. DOI: 10.1055/S-2009-1216490 |
0.546 |
|
| 2008 |
Daga PR, Doerksen RJ. Stereoelectronic properties of spiroquinazolinones in differential PDE7 inhibitory activity. Journal of Computational Chemistry. 29: 1945-54. PMID 18366018 DOI: 10.1002/Jcc.20960 |
0.585 |
|
| 2008 |
Bowling J, Daga P, Odde S, Ahmed S, Mesbah M, Youssef D, Kudrimoti S, Khalifa S, Doerksen R, Hamann M. Actin-binding Comparisons of the Marine Natural Product Latrunculin B with Natural and Semi-synthetic Latrunculin B Analogs Planta Medica. 74. DOI: 10.1055/S-2008-1075258 |
0.559 |
|
| 2007 |
Ahmed SA, Odde S, Daga PR, Bowling JJ, Mesbah MK, Youssef DT, Khalifa SI, Doerksen RJ, Hamann MT. Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking. Organic Letters. 9: 4773-6. PMID 17929935 DOI: 10.1021/Ol7020675 |
0.569 |
|
| 2005 |
Singh SK, Saibaba V, Rao KS, Reddy PG, Daga PR, Rajjak SA, Misra P, Rao YK. Synthesis and SAR/3D-QSAR studies on the COX-2 inhibitory activity of 1,5-diarylpyrazoles to validate the modified pharmacophore. European Journal of Medicinal Chemistry. 40: 977-90. PMID 15961192 DOI: 10.1016/J.Ejmech.2005.03.016 |
0.327 |
|
| 2005 |
Thaimattam R, Daga P, Rajjak SA, Banerjee R, Iqbal J. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies. Bioorganic & Medicinal Chemistry. 12: 6415-25. PMID 15556759 DOI: 10.1016/J.Bmc.2004.09.029 |
0.426 |
|
| 2004 |
Singh SK, Saibaba V, Ravikumar V, Rudrawar SV, Daga P, Rao CS, Akhila V, Hegde P, Rao YK. Synthesis and biological evaluation of 2,3-diarylpyrazines and quinoxalines as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry. 12: 1881-93. PMID 15051057 DOI: 10.1016/J.Bmc.2004.01.033 |
0.323 |
|
| Show low-probability matches. |